Finafloxacin

Finafloxacin Brand Name– XTORO

What is Finafloxacin

Finafloxacin is a fluoroquinolone otic suspension approved for treatment of acute otitis externa caused by Pseudomonas aeruginosa and Staphylococcus aureus.

Approval was based on the results of two clinical trials.

Data from these trials found recipients of finafloxacin achieved a 71% clinical cure rate at treatment day 11; of those clinically cured pathogen positive patients, the eradication rate for both P. aeruginosa and S. aureus was 89%.

Finafloxacin was FDA-approved for use in patients aged 1 year and older in December 2014.

Indications

  1. otitis externa
  2. Pseudomonas aeruginosa
  3. Staphylococcus aureus (MRSA)
  4. Staphylococcus aureus (MSSA)

Side Effects

  1. nausea
  2. pruritus

The most common adverse reactions reported in clinical trials with finafloxacin otic suspension were ear pruritus and nausea, which occurred at an incidence of 1%

Monitoring Parameters

  • laboratory monitoring not necessary

Contraindications

  • antimicrobial resistance
  • breast-feeding
  • pregnancy
  • quinolone hypersensitivity
  • viral infection

Interactions

No information is available regarding drug interactions associated with Finafloxacin

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856